William DeVinney

Counsel

Washington, D.C.
T +1 202.861.1554  |  F +1 202.861.1783

William DeVinney has a broad litigation practice that includes antitrust, intellectual property, commercial class action, securities, and other complex commercial litigation. He has extensive trial experience, both as a member of trial teams and as first chair in jury and bench trials, arbitrations proceedings, and regulatory hearings. William has also argued cases before several federal and state appellate courts. He also counsels clients on antitrust issues.

Select Experience

  • Member of team representing certified class of dairy farmers located in 14 Southeastern States against Dairy Farmers of America, Dean Foods, and a number of other defendants in an action alleging violations of Sections 1 and 2 of the Sherman Act by unlawfully conspiring to eliminate competition for marketing, sale, and purchase of raw milk in the Southeast United States. Litigation was settled for more than 70 percent of alleged damages.
  • Represented multinational consumer goods company in consumer class action alleging false advertising. Complaint against client dismissed with prejudice.
  • Represented multinational chemical and agricultural biotechnology corporation against Sherman Act Section 2 claim brought by competitor alleging that client had either monopolized or attempted to monopolize alleged market for transgenic corn seed.
More »

Experience

  • Member of team representing certified class of dairy farmers located in 14 Southeastern States against Dairy Farmers of America, Dean Foods, and a number of other defendants in an action alleging violations of Sections 1 and 2 of the Sherman Act by unlawfully conspiring to eliminate competition for marketing, sale, and purchase of raw milk in the Southeast United States. Litigation was settled for more than 70 percent of alleged damages.
  • Represented multinational consumer goods company in consumer class action alleging false advertising. Complaint against client dismissed with prejudice.
  • Represented multinational chemical and agricultural biotechnology corporation against Sherman Act Section 2 claim brought by competitor alleging that client had either monopolized or attempted to monopolize alleged market for transgenic corn seed.
  • Defended multinational chemical and agricultural biotechnology company accused of monopolizing market for transgenic corn seed industry. Motion for class certification by plaintiff rejected by trial court and before Third Circuit on appeal.
  • Represented multinational technology company in private antitrust claim brought by competitor, as well as in investigations brought by the EU, Federal Trade Commission, and state government enforcement agencies.
  • Defended former executive of Bankers Trust Corporation in criminal trial and related SEC administrative proceedings arising from alleged improper accounting treatment of unclaimed funds. After six-week jury trial, client was acquitted of all 36 counts in indictment and favorable settlement was reached with SEC.

Pro Bono

  • Served as lead counsel for three congressmen and a public interest group filing amicus brief in United States Supreme Court.
  • Represented several clients in fair housing cases in antidiscrimination, fair housing, landlord/tenant, and contractual disputes.

Services

Admissions

  • U.S. Supreme Court
  • U.S. Court of Appeals, Federal Circuit
  • U.S. District Court, District of Columbia
  • U.S. District Court, Eastern District of New York
  • U.S. District Court, Southern District of New York
  • District of Columbia
  • New York

Education

  • J.D., William & Mary Law School, 1998
  • B.S., Cornell University, 1991

Blog

In The Blogs

Previous Next
Antitrust Advocate
What to Expect From FTC during Trump Administration: New Leader Illuminates
February 16, 2017
On Jan. 25, President Trump named Maureen Ohlhausen as the Federal Trade Commission’s acting chairwoman. A recent speech by Ohlhausen, who has served as a commissioner for the FTC since 2012, shed some light on the role the FTC may have...
Read More ->
Antitrust Advocate
Carl Hittinger Examines American Monopolists through the Lens of History, Politics
February 2, 2017
Partner Carl Hittinger has authored a series of articles for The Legal Intelligencer that explores the history of select American monopolists by posing two fundamental questions: Why have some monopolists succeeded in gaining, maintaining...
Read More ->
Antitrust Advocate
Abrams, Commins, Foix Author Article on Antitrust Suit Counterclaims
January 23, 2017
Partners Robert Abrams, Gregory Commins and Danyll Foix authored an article published in “The Antitrust Review of the Americas 2017,” published by Global Competition Review. Their article, “United States: Private Antitrust Litigation,”...
Read More ->
Antitrust Advocate
FTC Still Ramping Up Antitrust Review of Health Care Mergers
December 15, 2016
Last month, we reported on the Federal Trade Commission’s (FTC) steady filing of injunctions to block what are effectively local mergers of small health care providers. In 2007, the FTC filed suit in Saint Alphonsus Medical Center v. St...
Read More ->
Antitrust Advocate
BakerHostetler Antitrust Lawyer Reviews Unusual Incentive Payment/Failing Firm Defense Remedy in Recent Hospital Merger
November 17, 2016
Antitrust Partner Danyll W. Foix wrote an article, published November 17, 2016 by Law360, reviewing the Federal Trade Commission’s acceptance of an unusual settlement for a challenged hospital merger, explaining that “the settlement ends...
Read More ->